-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new study was presented at the annual meeting of the European Research Association for Diabetes (Type 2), held online this year (September 1st, October 27th), and it was found that the COVID-19 response has resulted in more than one million diabetic patients without routine blood in the UK Testing them requires proper management of diabetes
Based on data from 6 testing centers covering approximately 6% of the total population of the UK, during the 6-month lockdown period (an average of 400,000 times per month), 2.
Across the country, there are 1.
It is important for diabetics to keep blood glucose levels as close to the normal range as possible
"As many as one-third of deaths from COVID-19 are among diabetes patients in the UK, it is more likely to be affected by the most severe virus because many cannot effectively manage their diabetes or treatment costs," said first author David of the Netherlands.
In this study, the researchers investigated the impact of the COVID-19 pandemic on the diagnosis and management of diabetes, using routinely collected laboratory data on key diabetes testing, glycosylated hemoglobin (HbA1c), which is based on the past three months Measurement of blood sugar level
Based on these data, the researchers estimated the number of missed tests for glycosylated hemoglobin for diagnostic and management purposes during the British lockdown from March 23 to September 30, 2020
The results showed that during the six months of the British lockdown, glycosylated hemoglobin testing dropped significantly
Researchers estimate that during the 6-month lockout period, diabetic patients missed 79,000 monitoring tests — 28,500 of which were performed on patients with poorly controlled diabetes, which led to missed blood sugar control goals, and thus This leads to the associated risk of complications
In addition, during the lockdown period, an estimated 149,000 high-risk groups were also missed in general screening, including nearly 27,000 missed pre-diabetes diagnosis
David Holland said: “The damage caused by COVID-19 is more than we realize
